Literature DB >> 23625042

Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model.

Wei Wang1, Xiayu Li, Danwei Zheng, Decai Zhang, Shuo Huang, Xuemei Zhang, Feiyan Ai, Xiaoyan Wang, Jian Ma, Wei Xiong, Yanhong Zhou, Guiyuan Li, Shourong Shen.   

Abstract

OBJECTIVE AND
DESIGN: Patients with ulcerative colitis have increased risk of colorectal carcinoma, but little is known about how peritoneal macrophages are involved in ulcerative colitis-associated carcinogenesis. We investigated the alteration of peritoneal macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis.
MATERIALS AND METHODS: Expression and functional changes in peritoneal macrophages and M1/M2 subpopulations were investigated by histopathology, flow cytometry, immunofluorescence, cytokines expression by ELISA and QRT-PCR in an azoxymethane (AOM)- and dextran sodium sulfate (DSS)-induced chemical colitis-associated carcinoma mouse model using male Crj:CD-1 (ICR) mice.
RESULTS: Striking evidence observed in histopathology, flow cytometry, cytokine detection, and gene expression analysis all revealed that inflammation-associated cytokines (IL-1β, IL-10, IL-12, IL-6, TNF-α) and migration/invasion-associated factors (G-CSF, GM-CSF, CXCR4, VEGF, TGF-β, ICAM-1) induced by peritoneal M2 macrophages increased significantly during the progression from inflammatory hyperplasia to carcinoma and metastasis. Similar functional changes occurred during peritoneal metastasis in M1 macrophages without changed polarization.
CONCLUSIONS: These results suggested that peritoneal M2 macrophages played a critical role in ulcerative colitis-associated carcinogenesis, including unbalanced pro-inflammatory and anti-inflammatory axis and enhanced expression of migration/invasion-associated factors. Furthermore, functional changes of M1 macrophages occurred without changed polarization during carcinogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625042     DOI: 10.1007/s00011-013-0619-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  41 in total

1.  Crohn's disease and ulcerative colitis: morbidity and mortality.

Authors: 
Journal:  Health Rep       Date:  1990       Impact factor: 4.796

Review 2.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

Review 3.  Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages?

Authors:  Liat Bar-On; Ehud Zigmond; Steffen Jung
Journal:  Semin Immunol       Date:  2011-02-02       Impact factor: 11.130

Review 4.  Nonresolving inflammation.

Authors:  Carl Nathan; Aihao Ding
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

Authors:  Eli Pikarsky; Rinnat M Porat; Ilan Stein; Rinat Abramovitch; Sharon Amit; Shafika Kasem; Elena Gutkovich-Pyest; Simcha Urieli-Shoval; Eithan Galun; Yinon Ben-Neriah
Journal:  Nature       Date:  2004-08-25       Impact factor: 49.962

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

8.  Promoting and synergistic effects of chrysazin on 1,2-dimethylhydrazine-induced carcinogenesis in male ICR/CD-1 mice.

Authors:  S Sugie; Y Mori; A Okumura; N Yoshimi; K Okamoto; S Sato; T Tanaka; H Mori
Journal:  Carcinogenesis       Date:  1994-06       Impact factor: 4.944

Review 9.  Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.

Authors:  G Solinas; G Germano; A Mantovani; P Allavena
Journal:  J Leukoc Biol       Date:  2009-09-09       Impact factor: 4.962

10.  Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer.

Authors:  Charles Bailey; Rupert Negus; Alistair Morris; Paul Ziprin; Robert Goldin; Paola Allavena; David Peck; Ara Darzi
Journal:  Clin Exp Metastasis       Date:  2007-03-28       Impact factor: 4.510

View more
  18 in total

Review 1.  Recent advancement in understanding colitis-associated tumorigenesis.

Authors:  Daren Low; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

2.  miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer.

Authors:  Leonie Mühlberg; Benjamin Kühnemuth; Eithne Costello; Victoria Shaw; Bence Sipos; Magdalena Huber; Heidi Griesmann; Sebastian Krug; Marvin Schober; Thomas M Gress; Patrick Michl
Journal:  Oncoimmunology       Date:  2016-05-09       Impact factor: 8.110

3.  LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.

Authors:  Feng Yao; Weizheng Zhou; Chenxi Zhong; Wentao Fang
Journal:  Tumour Biol       Date:  2015-05-07

4.  Local and systemic Th17 immune response associated with advanced stage colon cancer.

Authors:  Stephen P Sharp; Dorina Avram; Steven C Stain; Edward C Lee
Journal:  J Surg Res       Date:  2016-09-28       Impact factor: 2.192

5.  Modulation of the EMT/MET Process by E-Cadherin in Airway Epithelia Stress Injury.

Authors:  Li Han; Huaiqing Luo; Wenjie Huang; Jiang Zhang; Di Wu; Jinmei Wang; Jiao Pi; Chi Liu; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Yang Xiang
Journal:  Biomolecules       Date:  2021-04-30

6.  Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs.

Authors:  Feiyan Ai; Xuemei Zhang; Xiayu Li; Zailong Qin; Qiurong Ye; Li Tian; Anliu Tang; Nan Li; Guiyuan Li; Jian Ma; Shourong Shen
Journal:  Oncotarget       Date:  2015-03-10

7.  Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.

Authors:  Curtis J Henry; Rebecca L Sedjo; Andrii Rozhok; Jennifer Salstrom; Dennis Ahnen; Theodore R Levin; Ralph D'Agostino; Steven Haffner; James DeGregori; Tim Byers
Journal:  BMC Cancer       Date:  2015-03-14       Impact factor: 4.430

8.  Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages.

Authors:  Nour Eissa; Hayam Hussein; Laëtitia Kermarrec; Jasmine Grover; Marie-Hélène Et Metz-Boutigue; Charles N Bernstein; Jean-Eric Ghia
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

9.  Systemic neutrophil lymphocyte ratio and mismatch repair status in colorectal cancer patients: correlation and prognostic value.

Authors:  Wen-Zhuo He; Wan-Ming Hu; Peng-Fei Kong; Lin Yang; Yuan-Zhong Yang; Qian-Kun Xie; Chang Jiang; Chen-Xi Yin; Hui-Juan Qiu; Bei Zhang; Hui-Zhong Zhang; Liang-Ping Xia
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

Review 10.  The role of exosomal non-coding RNAs in cancer metastasis.

Authors:  Jin-Peng Wang; Yan-Yan Tang; Chun-Mei Fan; Can Guo; Yan-Hong Zhou; Zheng Li; Xiao-Ling Li; Yong Li; Gui-Yuan Li; Wei Xiong; Zhao-Yang Zeng; Fang Xiong
Journal:  Oncotarget       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.